NewslettersCancer Stem Cell NewsHepatic Cell News A New Triazolothiadiazine Derivative Inhibits Stemness and Induces Cell Death in HCC by Oxidative Stress Dependent JNK Pathway Activation By Danielle Corrigan - September 8, 2022 0 The authors investigated the cellular bioactivities of a series of triazolothiadiazine derivatives on hepatocellular carcinoma (HCC), which have been previously reported as potent analgesic/anti-inflammatory compounds. [Scientific Reports] Full Article